Effect of respiratory syncytial virus on the growth of hepatocellular carcinoma cell-lines

키워드

참고문헌 (33)

1. Parkin DM, "Global cancer statistics, 2002", CA Cancer J Clin, 55, pp.74~108 (2005)
2. Forver A, "Hepatocellular carcinoma", Lancet, 379, pp.1245~1255 (2012)
3. El-Serag HB, "Hepatocellular carcinoma:epidemiology and molecular carcinogenesis", Gastroenterology, 132, pp.2557~2576 (2007)
4. Hoofnagle JH, "Hepatocellular carcinoma: summary and recommendations", Gastroenterology, 127, pp.319~323 (2004)
5. Perz JF, "The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide", J Hepatol, 45, pp.529~538 (2006)
6. Douek M, "Good practice and quality assurance in surgical oncology", Lancet Oncol, 4, pp.626~630 (2003)
7. Llovet JM, "Hepatocellular carcinoma", Lancet, 362, pp.1907~1917 (2003)
8. Avila MA, "New therapies for hepatocellular carcinoma", Oncogene, 25, pp.3866~3884 (2006)
9. Woller N, "Oncolytic viruses as anticancer vaccines", Front Oncol, 4, pp.188~ (2014)
10. Russell SJ, "Oncolytic virotherapy", Nat Biotechnol, 30, pp.658~670 (2012)
11. Liu TC, "The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma", Mol Ther, 16, pp.1637~1642 (2008)
12. Kim JH, "Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSF", Mol Ther, 14, pp.361~370 (2006)
13. Heo J, "Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy", Mol Ther, 19, pp.1170~1179 (2011)
14. Heo J, "Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594in liver cancer", Nat Med, 19, pp.329~336 (2013)
15. 장준, "Current progress on development of respiratory syncytial virus vaccine", BMB Reports, 44(4), pp.232~237 (2011), 생화학분자생물학회
16. Atreya PL, "Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA", Virology, 261, pp.227~241 (1999)
17. Tregoning JS, "Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology", Clin Microbiol Rev, 23, pp.74~98 (2010)
18. Falsey AR, "Respiratory syncytial virus infection in adults", Clin Microbiol Rev, 13, pp.371~384 (2000)
19. Echchgadda I, "Anticancer oncolytic activity of respiratory syncytial virus", Cancer Gene Ther, 16, pp.923~935 (2009)
20. Echchgadda I, "Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense", BMC Cancer, 11, pp.43~ (2011)
21. Salimi V, "The Oncolytic Effect of Respiratory Syncytial Virus(RSV)in Human Skin Cancer Cell Line, A431", Iran Red Crescent Med J, 15, pp.62~67 (2013)
22. Kelly E, "History of Oncolytic Viruses:Genesis to Genetic Engineering", Mol Ther, 15, pp.651~659 (2007)
23. Kirn D, "Replication-selective virotherapy for cancer: Biological principles, risk management and future directions", Nat Med, 7, pp.781~787 (2001)
24. Bell JC, "Oncolytic viruses: what's next?", Curr Cancer Drug Targets, 7, pp.127~131 (2007)
25. Stanford MM, "Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer", Expert Opin Biol Ther, 7, pp.1415~1425 (2007)
26. Mohr I, "To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control", Oncogene, 24, pp.7697~7709 (2005)
27. Everts B, "Replication-selective oncolytic viruses in the treatment of cancer", Cancer Gene Ther, 12, pp.141~161 (2005)
28. Parato KA, "Recent progress in the battle between oncolytic viruses and tumours", Nat Rev Cancer, 5, pp.965~976 (2005)
29. Hey-Ryun Kim, "FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells", BMB Reports, 45(5), pp.287~292 (2012), 생화학분자생물학회[DOI]
30. 연종규, "PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson’s disease mouse model", BMB Reports, 47(10), pp.569~574 (2014), 생화학분자생물학회
31. Sol Kim, "Baculovirus-based Vaccine Displaying Respiratory Syncytial Virus Glycoprotein Induces Protective Immunity against RSV Infection without Vaccine-Enhanced Disease", Immune Network, 12(1), pp.8~17 (2012), 대한면역학회
32. 이영대, "Down-modulation of Bis reduces the invasive ability of glioma cells induced by TPA, through NF-κB mediated activation of MMP-9", BMB Reports, 47(5), pp.262~267 (2014), 생화학분자생물학회
33. 김덕수, "PEP-1-p18 prevents neuronal cell death by inhibiting oxidative stress and Bax expression", BMB Reports, 45(9), pp.532~537 (2012), 생화학분자생물학회

관련 논문AI추천